BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) announced today that a newly issued research report on the global market for liver assist devices projects that HepaLife Technologies, Inc. will be one of the two leading companies providing devices.